The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Polymer–drug conjugation, recent achievements and general strategies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110
A New Class of Polymers: Starburst-Dendritic Macromolecules
Tomalia, D. A., Baker, H., Dewald, J., Hall, M., Kallos, G., Martin, S., Roeck, J., Ryder, J., & Smith, P. (1985) · Polymer Journal · doi:10.1295/polymj.17.117 · Cited by 3,904
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Dendrimers and Other Dendritic Polymers
(2001) · Wiley eBooks · doi:10.1002/0470845821 · Cited by 1,429
Abuchowski, A., van Es, T., Palczuk, N. C., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40291-2 · Cited by 1,358
Abuchowski, A., McCoy, J. R., Palczuk, N. C., van Es, T., & Davis, F. F. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40292-4 · Cited by 1,274
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Dendrimers and other dendritic polymers
Fréchet, J. M. J., & Tomalia, D. A. (2001) · Cited by 873
An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines
Snyder, S. L., & Sobocinski, P. Z. (1975) · Analytical Biochemistry · doi:10.1016/0003-2697(75)90431-5 · Cited by 756
Yamaoka, T., Tabata, Y., & Ikada, Y. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830432 · Cited by 748
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Poly(ethylene glycol): Chemistry and Biological Applications
(1997) · ACS Symposium Series · doi:10.1021/bk-1997-0680 · Cited by 646
Polymer–drug conjugates: Progress in polymeric prodrugs
Khandare, J., & Minko, T. (2006) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.09.004 · Cited by 639
Bailon, P., Palleroni, A., Schaffer, C. A., Spence, C. L., Fung, W.-J., Porter, J. E., Ehrlich, G. K., Pan, W., Xu, Z.-X., Modi, M. W., et al. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000082g · Cited by 611
Schreiber, S., Rutgeerts, P., Fedorak, R. N., Khaliq–Kareemi, M., Kamm, M. A., Boivin, M., Bernstein, C. N., Staun, M., Thomsen, O. Ø., & Innes, A. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.064 · Cited by 580
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
PEGylated antibodies and antibody fragments for improved therapy: a review
Chapman, A. P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00026-1 · Cited by 556
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
Schellekens, H. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80075-3 · Cited by 556
Enhancement of therapeutic protein in vivo activities through glycoengineering
Elliott, S., Lorenzini, T., Asher, S., Aoki, K., Brankow, D., Buck, L., Busse, L., Chang, D., Fuller, J., Grant, J., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt799 · Cited by 510
Chemistry of Protein Conjugation and Cross Linking
Wong, S. S. (1991) · Medical Entomology and Zoology · Cited by 490
Seymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Wang, Y.-S., Youngster, S., Grace, M., Bausch, J., Bordens, R., & Wyss, D. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00027-3 · Cited by 420
Greenwald, R. B. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00331-5 · Cited by 353
Ganson, N. J., Kelly, S. J., Scarlett, E., Sundy, J. S., & Hershfield, M. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1861 · Cited by 350
Therapeutic antibody fragments with prolonged in vivo half-lives
Chapman, A. P., Antoniw, P., Spitali, M., West, S., Stephens, S., & King, D. J. (1999) · Nature Biotechnology · doi:10.1038/11717 · Cited by 350
Pegaspargase: a review of clinical studies
Graham, M. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00110-8 · Cited by 322
Mono-N-terminal poly(ethylene glycol)–protein conjugates
Kinstler, O., Molineux, G., Treuheit, M., Ladd, D., & Gegg, C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00023-6 · Cited by 306
The different faces of poly(ethylene glycol)
Israelachvili, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8378 · Cited by 303
Stiriba, S.-E., Kautz, H., & Frey, H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026835m · Cited by 302
Pharmacokinetic Consequences of Pegylation
Hamidi, M., Azadi, A., & Rafiei, P. (2006) · Drug Delivery · doi:10.1080/10717540600814402 · Cited by 301
Poly[N-(2-hydroxypropyl)methacrylamide]—I. Radical polymerization and copolymerization
Kopeček, J., & Baẑilová, H. (1973) · European Polymer Journal · doi:10.1016/0014-3057(73)90063-3 · Cited by 300
Fréchet, J. M. J., Hawker, C. J., Gitsov, I., & Leon, J. W. (1996) · Journal of Macromolecular Science, Part A · doi:10.1080/10601329608014916 · Cited by 287
Richter, A. W., & Åkerblom, E. (1983) · International Archives of Allergy and Immunology · doi:10.1159/000233309 · Cited by 282
Veronese, F. M., Schiavon, O., Pasut, G., Mendichi, R., Andersson, L., Tsirk, A., Ford, J., Wu, G., Kneller, S., Davies, J., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc040241m · Cited by 282
Self-citationStar and Hyperbranched Polymers
Kobayashi, S., & Mishra, M. (1999) · Medical Entomology and Zoology · Cited by 281
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
Shen, W.-C., & Ryser, H. J.-P. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91644-2 · Cited by 277
Measurements of attractive forces between proteins and end-grafted poly(ethylene glycol) chains
Sheth, S. R., & Leckband, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8399 · Cited by 273
Rejmanová, P., Kopeček, J., Pohl, J., Baudyš, M., & Kostka, V. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841006 · Cited by 264
A Branched Monomethoxypoly(ethylene glycol) for Protein Modification
Monfardini, C., Schiavon, O., Caliceti, P., Morpurgo, M., Harris, J. M., & Veronese, F. M. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00031a006 · Cited by 257
Self-citationClinical Pharmacokinetics of Interferons
Wills, R. J. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019050-00003 · Cited by 247
Long-acting Growth Hormones Produced by Conjugation with Polyethylene Glycol
Clark, R., Olson, K., Fuh, G., Marian, M., Mortensen, D., Teshima, G., Chang, S., Chu, H., Mukku, V., Canova-Davis, E., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21969 · Cited by 246
Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C
Rajender Reddy, K., Modi, M. W., & Pedder, S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00028-5 · Cited by 241
Effects of PEG conjugation on insulin properties
Hinds, K. D., & Kim, S. W. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00025-x · Cited by 240
Characterization and Stability of N-terminally PEGylated rhG-CSF
Kinstler, O. B., Brems, D. N., Lauren, S. L., Paige, A. G., Hamburger, J. B., & Treuheit, M. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016042220817 · Cited by 239
α and α Interferons and Their Receptor and Their Friends and Relations
UZÉ, G., LUTFALLA, G., & MOGENSEN, K. E. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.3 · Cited by 239
Poly(ethylene glycol): Chemistry and Biological Applications
Brannon-Peppas, L. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00212-6 · Cited by 238
Introduction and overview of peptide and protein pegylation
(2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 235
Microbial degradation of polyethers
Kawai, F. (2002) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-001-0850-2 · Cited by 225
Greenwald, R. B., Gilbert, C. W., Pendri, A., Conover, C. D., Xia, J., & Martinez, A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950475e · Cited by 223
Levy, Y., Hershfield, M. S., Fernandez-Mejia, C., Polmar, S. H., Scudiery, D., Berger, M., & Sorensen, R. U. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80271-3 · Cited by 215
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
Basu, A., Yang, K., Wang, M., Liu, S., Chintala, R., Palm, T., Zhao, H., Peng, P., Wu, D., Zhang, Z., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050322y · Cited by 213
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (1991) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(91)90040-j · Cited by 213
Site-specific PEGylation of a lysine-deficient TNF-α with full bioactivity
Yamamoto, Y., Tsutsumi, Y., Yoshioka, Y., Nishibata, T., Kobayashi, K., Okamoto, T., Mukai, Y., Shimizu, T., Nakagawa, S., Nagata, S., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt812 · Cited by 208
Duncan, R., Cable, H. C., Lloyd, J. B., Rejmanová, P., & Kopeček, J. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841005 · Cited by 193
Enzymatic procedure for site-specific pegylation of proteins
Sato, H. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00024-8 · Cited by 187
Hermeling, S., Schellekens, H., Maas, C., Gebbink, M. F. B. G., Crommelin, D. J. A., & Jiskoot, W. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20599 · Cited by 185
Drug-Polymer Conjugates Containing Acid-Cleavable Bonds
Kratz, F., Beyer, U., & Schutte, M. T. (1999) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v16.i3.10 · Cited by 181
pH distribution in human tumors
Thistlethwaite, A. J., Leeper, D. B., Moylan, D. J., & Nerlinger, R. E. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90217-2 · Cited by 177
GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli
DeFrees, S., Wang, Z.-G., Xing, R., Scott, A. E., Wang, J., Zopf, D., Gouty, D. L., Sjoberg, E. R., Panneerselvam, K., Brinkman-Van der Linden, E. C. M., et al. (2006) · Glycobiology · doi:10.1093/glycob/cwl004 · Cited by 174
Site-Specific PEGylation of Protein Disulfide Bonds Using a Three-Carbon Bridge
Balan, S., Choi, J.-W., Godwin, A., Teo, I., Laborde, C. M., Heidelberger, S., Zloh, M., Shaunak, S., & Brocchini, S. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0601471 · Cited by 172
Singer, J. W., Baker, B., de Vries, P., Kumar, A., Shaffer, S., Vawter, E., Bolton, M., & Garzone, P. D. (2004) · Advances in experimental medicine and biology · doi:10.1007/0-306-47932-x_6 · Cited by 168
Kaneko, T., Willner, D., Monkovic, I., Knipe, J. O., Braslawsky, G. R., Greenfield, R. S., & Vyas, D. M. (1991) · Bioconjugate Chemistry · doi:10.1021/bc00009a001 · Cited by 163
Protein PEGylation Decreases Observed Target Association Rates via a Dual Blocking Mechanism
Kubetzko, S., Sarkar, C. A., & Plückthun, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014910 · Cited by 163
Bioconjugation in pharmaceutical chemistry
Veronese, F. M., & Morpurgo, M. (1999) · Il Farmaco · doi:10.1016/s0014-827x(99)00066-x · Cited by 159
Self-citationReddy, K. R. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.10054 · Cited by 157
Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation
Maejima, Y., Adachi, S., Morikawa, K., Ito, H., & Isobe, M. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.10.012 · Cited by 156
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)
Danhauser-riedl, S., Hausmann, E., Schick, H.-D., Bender, R., Dietzfelbinger, H., Rastetter, J., & Hanauske, A.-R. (1993) · Investigational New Drugs · doi:10.1007/bf00874153 · Cited by 152
Protein, peptide and non-peptide drug PEGylation for therapeutic application
Pasut, G., Guiotto, A., & Veronese, F. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.6.859 · Cited by 145
Self-citationModulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study
Rajan, R. S., Li, T., Aras, M., Sloey, C. J., Sutherland, W., Arai, H., Briddell, R. A., Kinstler, O. B., Lueras, A. M. K., Zhang, Y., et al. (2006) · Protein Science · doi:10.1110/ps.052004006 · Cited by 140
Safety of Poly(ethylene glycol) and Poly(ethylene glycol) Derivatives
Working, P. K., Newman, M. S., Johnson, J. A., & Cornacoff, J. B. (1997) · ACS symposium series · doi:10.1021/bk-1997-0680.ch004 · Cited by 139
Extravasation of macromolecules
Takakura, Y., Mahato, R. I., & Hashida, M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00006-4 · Cited by 134
Murad, K. L., Mahany, K. L., Brugnara, C., Kuypers, F. A., Eaton, J. W., & Scott, M. D. (1999) · Blood · doi:10.1182/blood.v93.6.2121.406a30_2121_2127 · Cited by 133
Rowinsky, E. K., Rizzo, J. D., Ochoa, L., Takimoto, C. H. M., Forouzesh, B., Schwartz, G. H., Hammond, L. A., Patnaik, A., Kwiatek, J., Goetz, A. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.143 · Cited by 132
Fate of Water‐Soluble Polymers Administered via Different Routes
Yamaoka, T., Tabata, Y., & Ikada, Y. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840316 · Cited by 130
Identification of the Major Positional Isomer of Pegylated Interferon Alpha-2b
Wang, Y.-S., Youngster, S. K., Bausch, J. N., et al. (2000) · Biochemistry · doi:10.1021/bi000617t · Cited by 130
Duncan, R., Kopec̆ek, J., Rejmanová, P., & Lloyd, J. B. (1983) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(83)90258-1 · Cited by 127
A phase I and pharmacokinetic study of MAG-CPT, a water-soluble polymer conjugate of camptothecin
Schoemaker, N. E., van Kesteren, C., Rosing, H., Jansen, S., Swart, M., Lieverst, J. A., Fraier, D., Breda, M., Pellizzoni, C., Spinelli, R., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600516 · Cited by 122
Yang, K., Basu, A., Wang, M., Chintala, R., Hsieh, M.-C., Liu, S., Hua, J., Zhang, Z., Zhou, J. M., Li, M., et al. (2003) · Protein Engineering Design and Selection · doi:10.1093/protein/gzg093 · Cited by 119
Fujita, T., Nishikawa, M., Tamaki, C., Takakura, Y., Hashida, M., & Sezaki, H. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10504-1 · Cited by 119
Pegylated Interferon Alfa-2b Treatment for Patients With Solid Tumors: A Phase I/II Study
Bukowski, R. M., Ernstoff, M. S., Gore, M. E., Nemunaitis, J. J., Amato, R. J., Gupta, S. K., & Tendler, C. L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.051 · Cited by 117
The potential use of receptor-mediated endocytosis for oral drug delivery
Russell-Jones, G. J. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00131-p · Cited by 115
Monkarsh, S. P., Ma, Y., Aglione, A., Bailon, P., Ciolek, D., Debarbieri, B., Graves, M. C., Hollfelder, K., Michel, H., Palleroni, A. V., et al. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2128 · Cited by 114
Greenwald, R. B., Choe, Y. H., Conover, C. D., Shum, K. L., Wu, D., & Royzen, M. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990498j · Cited by 107
Mehvar, R. (2003) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201033489685 · Cited by 104
Poly(ethylene glycol) Multiblock Copolymer as a Carrier of Anti-Cancer Drug Doxorubicin
Pechar, M., Ulbrich, K., Šubr, V., Seymour, L. W., & Schacht, E. H. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990092l · Cited by 97
PEGylation of Proteins as Tailored Chemistry for Optimized Bioconjugates
Pasut, G., & Veronese, F. M. (2005) · Advances in polymer science · doi:10.1007/12_022 · Cited by 97
Self-citationPEG–Ara-C conjugates for controlled release
Schiavon, O., Pasut, G., Moro, S., Orsolini, P., Guiotto, A., & Veronese, F. M. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2003.10.005 · Cited by 95
Self-citationCheng, T., Cheng, C., Chen, B., Tsao, D.-A., Chuang, K.-H., Hsiao, S.-W., Lin, Y.-H., & Roffler, S. R. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050133f · Cited by 93
He, X., Shaw, P., & Tam, S.-C. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00257-x · Cited by 93
Berna, M., Dalzoppo, D., Pasut, G., Manunta, M., Izzo, L., Jones, A. T., Duncan, R., & Veronese, F. M. (2005) · Biomacromolecules · doi:10.1021/bm050480s · Cited by 92
Self-citationPEG-epirubicin Conjugates with High Drug Loading
Pasut, G., Scaramuzza, S., Schiavon, O., Mendichi, R., & Veronese, F. M. (2005) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911505053377 · Cited by 87
Self-citationAkiyama, Y., Otsuka, H., Nagasaki, Y., Kato, M., & Kataoka, K. (2000) · Bioconjugate Chemistry · doi:10.1021/bc000034w · Cited by 87
Estrogen modulation of osteoclast lysosomal enzyme secretion
Kremer, M., Judd, J., Rifkin, B. R., Auszmann, J. M., & Oursler, M. J. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240570211 · Cited by 83
Greenwald, R. B., Yang, K., Zhao, H., et al. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025652m · Cited by 79
Kelly, S. J., Delnomdedieu, M., Oliverio, M. I., WILLIAMS, D. L., Saifer, M. G. P., Sherman, M. R., Coffman, T. M., Johnson, G. A., & Hershfield, M. S. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251001 · Cited by 78
Bowen, S., Tare, N. S., Inoue, T., Yamasaki, M., Okabe, M., Horii, I., & Eliason, J. F. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(98)00051-4 · Cited by 77
Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1)
Duncan, R., Coatsworth, J. K., & Burtles, S. S. (1998) · Human & Experimental Toxicology · doi:10.1177/096032719801700204 · Cited by 76
Okamoto, C. T. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00080-x · Cited by 74
Na, D. H., Lee, K. C., & DeLuca, P. P. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2590-y · Cited by 69
Cheng, T., Chen, B., Chern, J., Wu, M., & Roffler, S. R. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990147j · Cited by 67
Peleg‐Shulman, T., Tsubery, H., Mironchik, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0497693 · Cited by 67
Gianasi, E., Buckley, R. G., Latigo, J. R., Wasil, M., & Duncan, R. (2002) · Journal of drug targeting · doi:10.1080/1061186021000072456 · Cited by 64
Cheng, P., Leung, Y., Lo, W., Tsui, S. M., & Lam, K. C. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.050 · Cited by 64
Zhao, H., Yang, K., Martinez, A. D., Basu, A., Chintala, R., Liu, H.-C., Janjua, A., Wang, M., & Filpula, D. R. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050270c · Cited by 63
Hooftman, G., Herman, S. O., & Schacht, E. H. (1996) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159601100205 · Cited by 59
Carboxyalkylated Histidine Is a pH-Dependent Product of Pegylation with SC-PEG
Wylie, D. C., Voloch, M., Lee, S., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1013006515587 · Cited by 47
Shepherd, J., Brodin, H. F. T., Cave, C. B., Waugh, N. R., Price, A., & Gabbay, J. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050063 · Cited by 46
CT-2103: A Novel Macromolecular Taxane with Potential Advantages Compared with Conventional Taxanes
Langer, C. J. (2004) · Clinical Lung Cancer · doi:10.3816/clc.2004.s.020 · Cited by 46
Santucci, L., Mencarelli, A., Renga, B., Pasut, G., Veronese, F. M., Zacheo, A., Germani, A., & Fiorucci, S. (2006) · The FASEB Journal · doi:10.1096/fj.05-4452fje · Cited by 46
Self-citationDautzenberg, H., Zintchenko, A., Koňák, Č., et al. (2001) · Langmuir · doi:10.1021/la001779t · Cited by 41
Ferruti, P., Knobloch, S., Ranucci, E., Duncan, R., & Gianasi, E. (1998) · Macromolecular Chemistry and Physics · Cited by 41
Beranová, M., Wasserbauer, R., Vančurová, D., Štifter, M., Očenášková, J., & Mára, M. (1990) · Biomaterials · doi:10.1016/0142-9612(90)90070-7 · Cited by 39
Delivery of Protein and Peptide Drugs in Cancer
Torchilin, V. P. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860948039 · Cited by 34
Chaves, F., Calvo, J. C., Carvajal, C., Monroy, Z. J. R., Ramírez, L., Pinto, M., Trujillo, M., Guzmán, F., & Patarroyo, M. E. (2001) · Journal of Peptide Research · doi:10.1034/j.1399-3011.2001.00921.x · Cited by 28
Wang, M., Basu, A., Palm, T., Hua, J., Youngster, S. K., Hwang, L. A., Liu, H.-C., Li, X., Peng, P., Zhang, Y., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060198y · Cited by 27
Jl, M., & Jd, M. (1965) · PubMed · Cited by 25
Development of N-(2-Hydroxypropyl)Methacrylamide Copolymers as Carriers of Therapeutic Agents
Duncan, R., Kopec̆ek, J., & Lloyd, J. B. (1983) · Springer eBooks · doi:10.1007/978-1-4615-7643-3_6 · Cited by 25
Boddy, A., Todd, R., Verrill, M., Sludden, J., Fishwick, K., Robson, L., Cassidy, J., Bisset, D., Garzone, P., & Calvert, A. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80747-x · Cited by 18
Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate
Todd, R., BODDY, A., Verrill, M., Sludden, J., Griffin, M., Elliott, S., Fishwick, K., Robson, L., Cassidy, J., Main, M., et al. (2001) · UCL Discovery (University College London) · doi:10.25405/ncl.34646574 · Cited by 9
Langer, C. J., O'Byrne, K. J., Ross, H. J., Socinski, M. A., Szczęsna, A., Dediu, M., Orlov, S., & Šmakal, M. (2005) · Lung Cancer · doi:10.1016/s0169-5002(05)80235-1 · Cited by 7
Cited by
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Polymers for Drug Delivery Systems
Liechty, W. B., Kryscio, D. R., Slaughter, B. V., & Peppas, N. A. (2010) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-073009-100847 · Cited by 1,608
Applications of Orthogonal “Click” Chemistries in the Synthesis of Functional Soft Materials
Iha, R. K., Wooley, K. L., Nyström, A. M., Burke, D. J., Kade, M. J., & Hawker, C. J. (2009) · Chemical Reviews · doi:10.1021/cr900138t · Cited by 1,468
Dendrimers: synthesis, applications, and properties
Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., Hanifehpour, Y., Nejati-Koshki, K., & Pashaei-Asl, R. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-247 · Cited by 1,279
Metadata
- Authors
- Pasut, G., & Veronese, F. M.
- Venue
- Progress in Polymer Science
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 32
- Issue
- 8-9
- Pages
- 933-961
- ISSN
- 0079-6700 (ISSN-L)
- OpenAlex
- W2034633336
- Cited by
- 616
- References
- 134
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.